We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$197M
Cap. Flow %
4.52%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$41.6M
2
DINO icon
HF Sinclair
DINO
+$6.4M
3
UNH icon
UnitedHealth
UNH
+$3.72M
4
TPYP icon
Tortoise North American Pipeline ETF
TPYP
+$2.48M
5
FANG icon
Diamondback Energy
FANG
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Utilities 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
276
Pfizer
PFE
$140B
$3K ﹤0.01%
120
-29,462
-100% -$687K
RCI icon
277
Rogers Communications
RCI
$17.7B
$3K ﹤0.01%
85
-63,235
-100% -$1.66M
FLR icon
278
Fluor
FLR
$7.29B
$2K ﹤0.01%
+45
New +$1.79K
OGN icon
279
Organon & Co
OGN
$3.55B
$2K ﹤0.01%
184
– –
VMEO
280
DELISTED
Vimeo
VMEO
$2K ﹤0.01%
524
– –
ANGI icon
281
Angi Inc
ANGI
$224M
$1K ﹤0.01%
+88
New +$1.27K
ICE icon
282
Intercontinental Exchange
ICE
$82.4B
$1K ﹤0.01%
8
– –
NKE icon
283
Nike
NKE
$61.9B
$1K ﹤0.01%
19
– –
NOC icon
284
Northrop Grumman
NOC
$77B
$1K ﹤0.01%
1
– –
RGP icon
285
Resources Connection
RGP
$129M
$1K ﹤0.01%
175
-14,018
-99% -$76.1K
ROST icon
286
Ross Stores
ROST
$76.6B
$1K ﹤0.01%
8
– –
RUSHA icon
287
Rush Enterprises Class A
RUSHA
$5.95B
$1K ﹤0.01%
20
-5,439
-100% -$276K
W icon
288
Wayfair
W
$11.1B
$1K ﹤0.01%
25
– –
CADE
289
DELISTED
Cadence Bank
CADE
– –
-5,488
Closed -$167K
CCI icon
290
Crown Castle
CCI
$32.7B
– –
-855
Closed -$89K
CHRW icon
291
C.H. Robinson
CHRW
$22B
$0 ﹤0.01%
2
– –
CRM icon
292
Salesforce
CRM
$134B
– –
-25
Closed -$7K
CVBF icon
293
CVB Financial
CVBF
$3.98B
– –
-6,044
Closed -$112K
DDOG icon
294
Datadog
DDOG
$87.9B
– –
-1
Closed –
DINO icon
295
HF Sinclair
DINO
$15.9B
– –
-194,667
Closed -$6.4M
FANG icon
296
Diamondback Energy
FANG
$57.6B
– –
-13,173
Closed -$2.11M
FHN icon
297
First Horizon
FHN
$12.1B
– –
-7,347
Closed -$143K
FTV icon
298
Fortive
FTV
$19B
$0 ﹤0.01%
3
-1
-25% -$52
HMN icon
299
Horace Mann Educators
HMN
$2.1B
– –
-2,023
Closed -$86K
KVUE icon
300
Kenvue
KVUE
$37B
$0 ﹤0.01%
15
-8,372
-100% -$190K
9 10 11
12
13

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.